Agalsidase Beta 58468-5030-01
- Manufacturer
- Genzyme Corporation
- Dosage Form
- Injection, Powder, Lyophilized, For Solution
- Product Type
- Drug For Further Processing
- Marketing Start
- October 10, 2003
- Listing Expires
- December 31, 2026
Active Ingredients
| Ingredient | Strength |
|---|---|
| Agalsidase Beta | 5 mg/mL |
Selected Package
58468-5030-01Selected1 mL in 1 VIAL (58468-5030-1)